Skip to main content

Table 1 Patient characteristics

From: Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer

 

cSCC

Non-cSCC

 
 

N = 27

N = 27

 

Age (years)a

61.7 (27–77)

61.3 (27–77)

p = 0.802

Gender (male)

19 (70.4%)

19 (70.4%)

p = 1

Years between Tx and first cSCCa

5.4 (0.9–12.5)

CMV status

  

p = 0.46

 Negative

12 (44.4%)

9 (33.3%)

 

 Positive

15 (55.6%)

17 (63.0%)

 

 Unknown

1 (3.7%)

 

Dialysis pre-transplantation

  

p = 0.783

 Yes

16 (59.3%)

15 (55.6%)

 

 No

11 (40.7%)

12 (44.4%)

 

ESRD diagnosis

  

p = 0.058

 Polycystic kidney

6 (22.2%)

1 (3.7%)

 

 Hypertension

6 (22.2%)

3 (11.1%)

 

 Diabetic nefropathy

1 (3.7%)

6 (22.2%)

 

 Glomerulonefritis

3 (11.1%)

6 (22.2%)

 

 Other

11 (40.7%)

11 (40.7%)

 

% CD3a

97.4 (92.4–99.5)

98.0 (95.1–99.5)

p = 0.225

% CD4a

73.0 (45.1–91.4)

60.3 (34.8–80.7)

p = 0.000

% CD8a

20.7 (5.8–46.2)

32.8 (14.8–60.6)

p = 0.000

  1. aMedian and range
  2. cSCC cutaneous squamous cell carcinoma, CMV cytomegalovirus, ESDR end-stage renal disease